Type 2 diabetes

Endocrinologist education sought by GPs on complex T2D therapy choices

GPs want more education from endocrinologists on the use of T2D therapies such as SGLT2 inhibitors, but finding the time and getting the format right appears to be a challenge for all parties. A study into why GPs are reluctant to take advantage of the extra-glycaemic benefits of SGLT2 inhibitors in type 2 diabetes has ...

Already a member?

Login to keep reading.

© 2021 the limbic